Reported Consolidated quarterly numbers for JK Paper are: Net Sales at Rs 1,682.93 crore in September 2024 up 1.99% from Rs. 1,650.04 crore in September 2023. Quarterly Net Profit at Rs. 128.51 crore in September 2024 down 57.5% from Rs. 302.35 crore in September 2023. EBITDA stands at Rs. 295.55 crore in September 2024 down 36.58% from Rs. 466.05 crore in September 2023.
Open FlipReported Consolidated quarterly numbers for Chemfab Alkalis are: Net Sales at Rs 81.90 crore in September 2024 up 2.91% from Rs. 79.58 crore in September 2023. Quarterly Net Loss at Rs. 0.53 crore in September 2024 down 112.42% from Rs. 4.30 crore in September 2023. EBITDA stands at Rs. 10.75 crore in September 2024 down 12.88% from Rs. 12.34 crore in September 2023.
Open FlipICICI Securities research report on Blue Jet Healthcare: Blue Jet Healthcare’s (BlueJet) Q2FY25 shows a ramp-up in contrast media as ABA HCL volumes normalise; the segment should see acceleration in growth with the commissioning of intermediate for NCE MRI molecule and iodinated ABA HCL from Q4FY25. BlueJet’s PI/API segment shone bright with higher volumes from cardiovascular molecule.
Open Flip